Comparison of glucose fluctuation between metformin combined with acarbose or sitagliptin in Chinese patients with type 2 diabetes: A multicenter, randomized, active-controlled, open-label, parallel design clinical trial

Authors

Xirui Wang (ORCID: https://orcid.org/0000-0003-4414-1270)
Xiaoling Cai (ORCID: https://orcid.org/0000-0002-7881-0543)
Linong Ji (ORCID: https://orcid.org/0000-0003-1305-1598)
Suiyuan Hu (ORCID: https://orcid.org/0000-0001-5368-1354)
Wenjia Yang (ORCID: https://orcid.org/0000-0003-0610-5121)
Junfen Wang
Zhufeng Wang (ORCID: https://orcid.org/0000-0002-8771-5118)
Jing Wu (ORCID: https://orcid.org/0000-0001-6890-0521)
Chu Lin (ORCID: https://orcid.org/0000-0002-2365-9831)
Ling Chen
Xiaomei Zhang (ORCID: https://orcid.org/0000-0001-7978-8352)
Lin Nie
Fengmei Xu

Institutions

Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
Peking University (CN)
Hefei Design and Research Institute of Coal Industry (China) (CN)
First Hospital of Shijiazhuang (CN)
Peking University People's Hospital (CN)
Peking University International Hospital (CN)
Guang’anmen Hospital (CN)
Airport Shunyi District Hospital (CN)

Publication Details

Journal: Chinese Medical Journal
Published: 2025-04-03
DOI: https://doi.org/10.1097/cm9.0000000000003477
Citations: 1
Primary Topic: Diabetes Treatment and Management
Type: article
Field-Weighted Citation Impact: 1.29

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Comparison of glucose fluctuation between metformin combined with acarbose or sitagliptin in Chinese patients with type 2 diabetes: A multicenter, randomized, active-controlled, open-label, parallel design clinical trial

Xirui Wang, Xiaoling Cai, Linong Ji, Suiyuan Hu et al.

Apr 3, 2025

1 citations

Chinese Medical Journal

Diabetes Treatment and Management

1.29

article

Comparison of glucose fluctuation between metformin combined with acarbose or sitagliptin in Chinese patients with type 2 diabetes: A multicenter, randomized, active-controlled, open-label, parallel design clinical trial

Xirui Wang, Xiaoling Cai, Linong Ji, Suiyuan Hu, Wenjia Yang, Junfen Wang, Zhufeng Wang, Jing Wu, Chu Lin, Ling Chen, Xiaomei Zhang, Lin Nie, Fengmei Xu

April 3, 2025article en

1 citations

Abstract

No abstract available for this paper.

Chinese Medical JournalVol. 138(9)

Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Peking University (CN), Hefei Design and Research Institute of Coal Industry (China) (CN), First Hospital of Shijiazhuang (CN), Peking University People's Hospital (CN), Peking University International Hospital (CN), Guang’anmen Hospital (CN), Airport Shunyi District Hospital (CN)

Good health and well-being

Openalex Percentile: Top 21%

Diabetes Treatment and Management

1.29

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Comparison of glucose fluctuation between metformin combined with acarbose or sitagliptin in Chinese patients with type 2 diabetes: A multicenter, randomized, active-controlled, open-label, parallel design clinical trial — Xirui Wang, Xiaoling Cai, et al. · Chinese Medical Journal (2025) | TGRS Research Map | TGRS